Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-15
    E.g., 2018-10-15

Archive Search

Pages

18 results
12:00 AM, Jun 13, 2005  |  BC Week In Review | Clinical News  |  Regulatory

Adacel regulatory update

FDA approved a BLA for Adacel tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed for adolescents …
12:00 AM, Mar 21, 2005  |  BC Week In Review | Clinical News  |  Regulatory

Adacel regulatory update

Biological Products Advisory Committee unanimously recommended approval of Adacel tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine
12:00 AM, Jan 31, 2000  |  BC Week In Review | Clinical News  |  Preclinical Results

North American Vaccine preclinical data

NVX reported that in mice the combination of its Hib and acellular pertussis vaccines produced no significant immunologic …
vaccine, which is in preclinical development, in combination with its marketed Certiva diphtheria, tetanus and acellular pertussis vaccine
12:00 AM, Nov 01, 1999  |  BC Week In Review | Clinical News  |  Clinical Status

Haemophilus influenzae type b (Hib) conjugate vaccine: Began Phase I testing

to begin testing the Hib vaccine in combination with its Certiva DTaP diphtheria, tetanus and acellular pertussis vaccine
12:00 AM, May 03, 1999  |  BC Week In Review | Clinical News  |  Regulatory

North American Vaccine regulatory update

Austria granted marketing approval for NVX's DTaP, a combined diphtheria, tetanus and acellular pertussis vaccine, and its DTaP-IPV …
12:00 AM, Mar 23, 1998  |  BC Week In Review | Clinical News  |  Regulatory

Chiron, Evans Medical Ltd. regulatory update

0 162 639 covering the pertactin antigen of Bordetella pertussis, which is used in CHIR's acellular pertussis vaccine
ends Evans's litigation against CHIR in the U.K., Italy and the Netherlands alleging that CHIR's acellular pertussis vaccines …
12:00 AM, Jan 19, 1998  |  BC Week In Review | Company News  |  Other News

Chiron, Evans Medical Ltd. infectious diseases news

bordetella pertussis used in CHIR's pertussis vaccines. CHIR has completed clinical trials for its two acellular pertussis vaccines …
Acelluvax, a genetically engineered acellular pertussis vaccine, and TriAcelluvax, a combination vaccine that includes diphtheria and tetanus. Evans …
12:00 AM, Jan 06, 1997  |  BC Week In Review | Clinical News  |  Regulatory

Wyeth-Lederle Vaccines and Pediatrics regulatory update

The FDA licensed Acel-Imune, an acellular pertussis vaccine containing diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, for all …
12:00 AM, Oct 07, 1996  |  BC Week In Review | Clinical News  |  Regulatory

North American Vaccine regulatory update

The vaccine, which was developed jointly by NVX and Statens Seruminstitut (Copenhagen, Denmark), uses NVX's acellular pertussis vaccine
12:00 AM, Oct 07, 1996  |  BC Week In Review | Clinical News  |  Regulatory

Connaught Laboratories Inc. regulatory update

The FDA licensed a combination vaccine that incorporates a Haemophilus vaccine with an acellular pertussis vaccine for the …
ActHIB Haemophilus b Conjugate Vaccine (tetanus toxoid conjugate) and Tripedia (diphtheria and tetanus toxoids and acellular pertussis vaccine

Pages